High Seroprevalence of Hepatitis E Virus Among Patients With Hepatitis B and Those With Hepatitis of Unknown Etiology in Central Vietnam - Takeaways - MDSpire

High Seroprevalence of Hepatitis E Virus Among Patients With Hepatitis B and Those With Hepatitis of Unknown Etiology in Central Vietnam

  • By

  • Le Chi Cao

  • Tran Thi Tien Xinh

  • Taanvi Gowdar

  • Dang Ngoc Phuoc

  • Nguyen Thi Dung

  • Tran Thi Kim Loan

  • Pham Van Duc

  • Dao Thi Huyen

  • Le Thi Kieu Linh

  • Le Huu Song

  • Thirumalaisamy P Velavan

  • June 26, 2025

  • 0 min

Share

  • 1

    The study found an anti-HEV IgG seroprevalence of 26% in patients with HBV and 36% in those with hepatitis of unknown etiology in Central Vietnam.

  • 2

    Patients with liver cirrhosis and hepatocellular carcinoma had the highest anti-HEV IgG seroprevalence at 46%, while symptomatic chronic hepatitis B patients had the lowest at 24%.

  • 3

    Only 1 patient (0.1%) tested positive for anti-HEV immunoglobulin M, and no HEV RNA positivity was detected among the study participants.

  • 4

    Biochemical parameters in patients with liver diseases showed no association with anti-HEV seropositivity, indicating limited impact of HEV on liver disease progression.

  • 5

    The findings suggest that HEV is not a common cause of hepatitis in Central Vietnam, despite relatively high seroprevalence among chronic liver disease patients.

Original Source(s)

High Seroprevalence of Hepatitis E Virus Among Patients With Hepatitis B and Those With Hepatitis of Unknown Etiology in Central Vietnam

  • by Le Chi Cao, Tran Thi Tien Xinh, Taanvi Gowdar, Dang Ngoc Phuoc, Nguyen Thi Dung, Tran Thi Kim Loan, Pham Van Duc, Dao Thi Huyen, Le Thi Kieu Linh, Le Huu Song, Thirumalaisamy P Velavan

  • June 26, 2025

Related Content

Diurnal Light Exposure and Rest-Activity Rhythms in Relation to MASLD: Insights From 2 Nationwide Cohort Studies

Evaluation of Liver Fibrosis Change After DAA-induced Cure of Hepatitis C in Participants With and Without HIV: ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (VHICS)

Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease